XORTX Therapeutics Inc (XRTX)
2.677
+0.08
(+3.01%)
USD |
NASDAQ |
May 03, 16:00
2.68
0.00 (0.00%)
Pre-Market: 20:00
XORTX Therapeutics Price: 2.677 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.552 | 2.847 | 2.55 | 2.677 | 3591.00 |
May 02, 2024 | 2.52 | 2.70 | 2.52 | 2.599 | 4294.00 |
May 01, 2024 | 2.626 | 2.65 | 2.535 | 2.562 | 2595.00 |
Apr 30, 2024 | 2.698 | 2.75 | 2.55 | 2.55 | 10521.00 |
Apr 29, 2024 | 3.12 | 3.24 | 2.56 | 2.645 | 48519.00 |
Apr 26, 2024 | 2.75 | 3.00 | 2.530 | 2.93 | 25186.00 |
Apr 25, 2024 | 2.79 | 2.84 | 2.510 | 2.59 | 26337.00 |
Apr 24, 2024 | 2.96 | 3.000 | 2.846 | 2.902 | 10960.00 |
Apr 23, 2024 | 2.700 | 2.944 | 2.700 | 2.94 | 8353.00 |
Apr 22, 2024 | 2.82 | 3.00 | 2.82 | 3.00 | 23414.00 |
Apr 19, 2024 | 2.955 | 3.00 | 2.90 | 2.997 | 13020.00 |
Apr 18, 2024 | 3.16 | 3.16 | 2.83 | 3.050 | 30676.00 |
Apr 17, 2024 | 3.03 | 3.23 | 3.00 | 3.17 | 4048.00 |
Apr 16, 2024 | 3.10 | 3.180 | 3.060 | 3.10 | 8604.00 |
Apr 15, 2024 | 3.37 | 3.550 | 3.11 | 3.22 | 7909.00 |
Apr 12, 2024 | 3.56 | 3.56 | 3.36 | 3.36 | 11737.00 |
Apr 11, 2024 | 3.646 | 3.67 | 3.520 | 3.555 | 11266.00 |
Apr 10, 2024 | 3.65 | 3.84 | 3.500 | 3.514 | 14127.00 |
Apr 09, 2024 | 3.92 | 3.92 | 3.70 | 3.81 | 11610.00 |
Apr 08, 2024 | 3.72 | 3.92 | 3.38 | 3.905 | 21360.00 |
Apr 05, 2024 | 3.46 | 3.73 | 3.347 | 3.70 | 16158.00 |
Apr 04, 2024 | 3.14 | 3.67 | 3.14 | 3.53 | 27730.00 |
Apr 03, 2024 | 3.46 | 3.46 | 3.07 | 3.25 | 31121.00 |
Apr 02, 2024 | 3.74 | 3.77 | 3.35 | 3.375 | 26489.00 |
Apr 01, 2024 | 3.79 | 3.79 | 3.60 | 3.64 | 5839.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.01
Minimum
Dec 28 2023
64.45
Maximum
Sep 07 2021
12.59
Average
11.59
Median
Aug 01 2019
Price Benchmarks
ImmunoPrecise Antibodies Ltd | 1.28 |
Acasti Pharma Inc | 2.96 |
Aurinia Pharmaceuticals Inc | 5.10 |
Edesa Biotech Inc | 4.632 |
Lexaria Bioscience Corp | 3.13 |
Price Related Metrics
Price to Book Value | 1.672 |
Earnings Yield | -41.47% |
Market Cap | 7.760M |